Fingerprint
Dive into the research topics of 'Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically